2013 Achievement Award Recipients Honored at Annual Meeting
Announcing three special sessions during ARVO 2013 Annual Meeting
ARVO is pleased to host three special sessions during the 2013 Annual Meeting (May 5 – 9) in Seattle, Wash. These sessions will take place at the Washington State Convention Center.
ARVO Foundation congratulates 2012 Vistakon Fellowship recipients
The ARVO Foundation for Eye Research announces Geraint John Parfitt, BSc, PhD and Jerome Gabriel Mauris, PhD, as recipients of the 2012 Vistakon Dry Eye Research. Each received $40,000 to support their basic research of meibomian gland dysfunction (MGD) and dry eye disease.
ARVO Foundation announces 2012 Genentech Fellowship recipients
The ARVO Foundation for Eye Research congratulates the 2012 recipients of the Genentech Age-related Macular Degeneration Research Fellowships – Venkata Chavali, MSc, PhD and Helder A.M.B. André, PharmD, PhD. Each received $40,000 to support their age-related macular degeneration (AMD) research.
Three distinguished keynote speakers to present during ARVO 2013 Annual Meeting
The ARVO 2013 Annual Meeting will feature lectures from three keynote speakers, including two Nobel laureates, during the organization’s five-day conference, May 5 – 9 in Seattle, Wash.
Treating eye diseases with anti-VEGF therapies may have side effects
A new IOVS
article reveals that increasingly aggressive therapies that block VEGF might have a harmful effect on the tissue responsible for producing the fluid that bathes the eye, medically termed the ciliary body.
Fear of falling may cause social isolation in older adults with vision problems
A new study published in Investigative Ophthalmology & Visual Science
found that between 40 to 50 percent of older adults with visually impairing eye disease limit their activities due to a fear of falling.
Glaucoma study could inspire e-reader apps
According to a new scientific study published in Investigative Ophthalmology & Visual Science
, adults with glaucoma read slower when reading silently for long periods of time and are more likely to have their reading speed decrease over time.
Forum to bring together leading-edge ophthalmic researchers and investors
Thenewest ophthalmic innovations with market potential will be the focus of aone-day seminar in Seattle on May 3, 2013 that will connect scientists, venturecapitalists, pharmaceutical representatives and others.
Smoking may lead to cataracts in aging population
Cigarette smoking is a well-known risk factor for a wide-range of diseases. Now, scientists have evidence that smoking may also increase the risk of age-related cataract, the leading cause of blindness and vision loss in the world.
New study links caffeinated coffee to vision loss
According to a scientific paper in Investigative Ophthalmology & Visual Science
, heavy caffeinated coffee consumption is associated with an increased risk of developing exfoliation glaucoma, the leading cause of secondary glaucoma worldwide.
Is arm length the reason women need reading glasses sooner than men?
Studies have consistently reported that women require reading glasses or bifocal lenses earlier than men. According to a recent IOVS
paper, the gender difference is caused by factors other than focusing ability, such as arm length or preferred reading distance.
A toothy grin or angry snarl makes it easy to stand out in a crowd
Scientists have found new evidence that people spot a face in the crowd more quickly when teeth are visible — whether smiling or grimacing — than a face with a particular facial expression.
Increased use of hand held devices may call for new photo guidelines
Viewing photos on a smart phone are becoming common practice. But according to a recently published Journal of Vision study, pictures on the small screen often appear distorted.
Khaw begins term as ARVO president New vice presidents installed; future officers named
Peng T. Khaw, MD, PhD, FARVO, of Moorfields Eye Hospital and UCL Institute of Ophthalmology is the new president of ARVO.
2012 ARVO Award recipients honored at Annual Meeting
ARVO is pleased to announce its 2012 ARVO Award recipients. These award recipients will be acknowledged at the ARVO 2012 Annual Meeting, May 6 – 10, in Fort Lauderdale, Fla.
Presentation of one-year IVAN and two-year CATT Study results
ARVO will host a presentation of the one-year results from the U.K.’s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.
Ultra wide-angle imaging may help uncover link between Alzheimer’s Disease and AMD
A pilot study examining macular and peripheral pathologies in the retina in patients with Alzheimer’s dementia found potential value in an ultra-wide angle laser scanning ophthalmoscope.
Can a standard vision test predict nighttime driving performance?
A recent study found that the frequency and distance at which drivers with moderate levels of blurred vision and cataracts recognize pedestrians at night was severely reduced, even when the drivers have passed the required vision test.
Nintendo Wii™ game controllers help diagnose eye disorder
Wii remotes are not all about fun and games. Scientists can use them to assess and diagnose children with an abnormal head position caused by eye diseases.